These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 9171744

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease.
    Li L, Szeto CC, Kwan BC, Chow KM, Leung CB, Kam-Tao Li P.
    Am J Kidney Dis; 2011 Jun; 57(6):903-7. PubMed ID: 21458901
    [Abstract] [Full Text] [Related]

  • 4. [The relation of hypertension, renal function and cardiovascular events in autosomal dominant polycystic kidney disease].
    Idrizi A, Barbullushi M, Strakosha A, Kodra S, Thereska N, Zaimi E, Gjyzari A, Petrela E.
    G Ital Nefrol; 2007 Jun; 24(6):595-9. PubMed ID: 18278763
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Management of ESRD in patients with autosomal dominant polycystic kidney disease.
    Alam A, Perrone RD.
    Adv Chronic Kidney Dis; 2010 Mar; 17(2):164-72. PubMed ID: 20219619
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of colonic diverticular disease in autosomal dominant polycystic kidney disease without end-stage renal disease.
    Sharp CK, Zeligman BE, Johnson AM, Duley I, Gabow PA.
    Am J Kidney Dis; 1999 Nov; 34(5):863-8. PubMed ID: 10561142
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Earlier diagnosis of autosomal dominant polycystic kidney disease: importance of family history and implications for cardiovascular and renal complications.
    Taylor M, Johnson AM, Tison M, Fain P, Schrier RW.
    Am J Kidney Dis; 2005 Sep; 46(3):415-23. PubMed ID: 16129202
    [Abstract] [Full Text] [Related]

  • 14. Autosomal dominant polycystic kidney disease: clinical and genetic aspects.
    Sessa A, Ghiggeri GM, Turco AE.
    J Nephrol; 1997 Sep; 10(6):295-310. PubMed ID: 9442442
    [Abstract] [Full Text] [Related]

  • 15. Hypertension in autosomal dominant polycystic kidney disease: observational study in 207 patients with a mean follow-up of 107 months.
    De Almeida EA, Prata MM.
    Rev Port Cardiol; 2007 Nov; 26(11):1173-82. PubMed ID: 18297839
    [Abstract] [Full Text] [Related]

  • 16. Are large nonfunctional kidneys risk factors for posttransplantation urinary tract infection in patients with end-stage renal disease due to autosomal dominant polycystic kidney disease?
    Salehipour M, Jalaeian H, Salahi H, Bahador A, Davari HR, Nikeghbalian S, Sagheb MM, Raiss-Jalali GA, Roozbeh J, Behzadi S, Janghorban P, Sepas HN, Malek-Hosseini SA.
    Transplant Proc; 2007 May; 39(4):887-8. PubMed ID: 17524840
    [Abstract] [Full Text] [Related]

  • 17. Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease.
    Hoevenaren IA, Wester R, Schrier RW, McFann K, Doctor RB, Drenth JP, Everson GT.
    Liver Int; 2008 Feb; 28(2):264-70. PubMed ID: 17927714
    [Abstract] [Full Text] [Related]

  • 18. Outcome of kidney transplantation in patients with polycystic kidney disease: a single center study.
    Roozbeh J, Razmkon AR, Jalaeian H, Raiss-Jalali GA, Behzadi S, Sagheb MM, Salahi H, Bahador A, Nikeghbalian S, Davari HR, Salehipour M, Malek-Hosseini SA.
    Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):72-5. PubMed ID: 18087127
    [Abstract] [Full Text] [Related]

  • 19. Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality.
    Perrone RD, Ruthazer R, Terrin NC.
    Am J Kidney Dis; 2001 Oct; 38(4):777-84. PubMed ID: 11576881
    [Abstract] [Full Text] [Related]

  • 20. Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population.
    Kelleher CL, McFann KK, Johnson AM, Schrier RW.
    Am J Hypertens; 2004 Nov; 17(11 Pt 1):1029-34. PubMed ID: 15533729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.